Calmodulin D133H Disrupts Cav1.2 and Kv7.1 Regulation to Prolong Cardiac Action Potentials in Long QT Syndrome
Cells · 2025
DOI: 10.3390/cells14221763 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2025. Verfasst von Nitika Gupta und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Cell and Systems Biology, Institute of Systems, Molecular and Integrative Biology, Faculty of Health and Life Sciences, U…. Hauptthemen laut MEDLINE: Calmodulin, Long QT Syndrome, Action Potentials, Calcium Channels, L-Type. Die Arbeit nennt 136 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Heart Research Wales, British Heart Foundation, University of Liverpool.
Abstract (Originalsprache)
Calmodulin (CaM) plays a central role in cardiac excitation–contraction coupling by regulating ion channels, including the L-type calcium (Ca2+) channel Cav1.2 and the voltage-gated potassium (K+) channel Kv7.1. Mutations in CaM are linked to severe arrhythmogenic disorders such as Long QT syndrome (LQTS), yet the molecular mechanisms remain incompletely understood. Here, we investigate the structural and functional consequences of the arrhythmia-associated CaM variant D133H. Biophysical analysis revealed that D133H destabilises Ca2+ binding at the C-terminal lobe of CaM, altering its Ca2+-dependent conformational changes. Electrophysiological recordings demonstrated that CaM D133H impairs Ca2+-dependent inactivation (CDI) of Cav1.2, prolonging Ca2+ influx, while also reducing activation of Kv7.1, thereby limiting repolarising K+ currents. Together, these dual defects converge to prolong action potential duration, providing a mechanistic basis for arrhythmogenesis in LQTS. Our findings establish that CaM D133H perturbs both Ca2+ and K+ channel regulation, highlighting a shared pathway by which calmodulinopathy mutations disrupt cardiac excitability.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, Cell and Systems Biology, Institute of Systems, Molecular and Integrative Biology, Faculty of Health and Life Sciences, University of Liverpool, Liverpool L69 7ZB, UK.
- Genomic Diagnostics Laboratory, Manchester Centre for Genomic Medicine, St Mary's Hospital, Manchester M13 9WL, UK.
- School of Biosciences, College of Biomedical and Life Sciences, Cardiff University, Cardiff CF10 3AX, UK.
ORCID-Profile: Nitika Gupta, Liam F McCormick, Ewan D Fowler, Nordine Helassa
Förderung
- Heart Research Wales
- British Heart Foundation
- University of Liverpool
- Wellcome Trust
- Biotechnology and Biological Sciences Research Council
- British Heart Foundation Intermediate Basic Science Research Fellowship
- British Heart Foundation non-clinical PhD studentship
- BBSRC
Zitieren
APA
Gupta, N., McCormick, L. F., Richards, E. M. B., Wadmore, K., Morris, R., Morris, V. S., Kirilenko, P., Fowler, E. D., Dart, C., & Helassa, N. (2025). Calmodulin D133H Disrupts Cav1.2 and Kv7.1 Regulation to Prolong Cardiac Action Potentials in Long QT Syndrome. Cells. https://doi.org/10.3390/cells14221763
Vancouver
Gupta N, McCormick LF, Richards EMB, Wadmore K, Morris R, Morris VS, et al. Calmodulin D133H Disrupts Cav1.2 and Kv7.1 Regulation to Prolong Cardiac Action Potentials in Long QT Syndrome. Cells. 2025. doi:10.3390/cells14221763
BibTeX
@article{Gupta2025,
author = {Gupta, Nitika and McCormick, Liam F and Richards, Ella M B and Wadmore, Kirsty and Morris, Rachael and Morris, Vanessa S and Kirilenko, Pavel and Fowler, Ewan D and Dart, Caroline and Helassa, Nordine},
title = {Calmodulin D133H Disrupts Cav1.2 and Kv7.1 Regulation to Prolong Cardiac Action Potentials in Long QT Syndrome},
journal = {Cells},
year = {2025},
doi = {10.3390/cells14221763}
}
EUVIMED